A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio Urges Treasury Not to Weaken Divestment Requirements for Chinese Military Companies
Washington, D.C. — U.S. Senator Marco Rubio (R-FL) sent a letter to U.S. Department of the Treasury Secretary Janet Yellen regarding recent policy “clarifications” by the Office of Foreign Assets Control, which will allow U.S. persons to maintain investments in Chinese Military-Industrial Complex Companies (CMIC) after the 365-day divestment period. This policy runs counter to former President Trump’s Executive Order to curb such investment and weakens critical tools to confront the national security threat posed by these state-directed companies.
“By overturning these restrictions days before they were slated to go into effect, OFAC has weakened a core tool at its disposal for confronting the critical threat posed to Americans by Chinese companies operating in the defense, aerospace, and surveillance sectors,” Rubio wrote. “I strongly urge the Department to undo these changes so that the Non-SDN Chinese Military-Industrial Complex Companies List can be fully employed to deprive these firms of American capital as intended.”
The full text of the letter is below.
Dear Secretary Yellen:
I write to convey concern with regard to recent actions taken by the U.S. Department of the Treasury and its Office of Foreign Assets Control (OFAC) regarding the implementation of Executive Order (E.O.) 13959, as amended by E.O. 14032. Recent updates to the policy, released in the form of new responses to “frequently asked questions” (FAQs) published by OFAC this month, risk diminishing its effectiveness in curbing the influence and power of Chinese Military Industrial Complex Companies (CMIC), as well as undoing the intent of the original order as it was first enacted.
When President Biden updated and superseded President Trump’s E.O. 13959 on June 3, 2021, he declared that he did so to prevent “U.S. investment from supporting the Chinese defense sector” and to announce that his “Administration will not hesitate to prevent U.S. capital from flowing into the [People’s Republic of China’s] defense and related materiel sector.” With the introduction of two new FAQs on June 1, 2022, OFAC has now provided several substantive updates squarely in tension with such objectives.
First, via FAQ 1046,1 OFAC has indicated that the Department’s 365-day divestment period was, in fact, permissive – in other words, optional, as some observers feared when President Biden first announced E.O. 14032. By disclosing that there will be no penalties for failure to divest of targeted securities of CMIC entities, OFAC has minimized the essential importance of depriving Chinese military companies access to American capital. This is unacceptable and runs directly counter to U.S. national security priorities.
At the same time, OFAC has banned U.S. investors from closing positions after that 365day divestment period, absent OFAC authorization. The confusing net consequence of this is that U.S. investors who failed to divest in CMIC securities during that period are seemingly stuck holding on to their positions for the indefinite future. This risks playing into some investors’ hopes that Chinese firms’ listings are simply temporary or that the CMIC list itself will eventually be retired2, and that they stand to profit in the future because they declined to divest.
This perception is only encouraged by FAQ 1047,3 which confirms that not only are there no consequences for refusing to divest, but also that U.S. persons may continue to profit off of their investments in Chinese military companies via passive benefits, such as cash dividends and stock splits.
By overturning these restrictions days before they were slated to go into effect, OFAC has weakened a core tool at its disposal for confronting the critical threat posed to Americans by Chinese companies operating in the defense, aerospace, and surveillance sectors. I strongly urge the Department to undo these changes so that the Non-SDN Chinese Military-Industrial Complex Companies List can be fully employed to deprive these firms of American capital as intended.
Thank you for your attention to this matter.
Sincerely,